tirzepatide prescribing information guidelines Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For Tirzepatide dose chart: complete dosing

Insulin or sulfonylurea doses may need adjustment to prevent hypoglycaemia

Theyre easier to store, dont require injections, and may open the door for people whove wanted help but werent ready for a shot

10.1073/pnas.96.26.14843 24

Sometimes coverage is available for other FDA-approved uses, such as Zepbound for obstructive sleep apnea or Wegovy for cardiovascular protection

Acid stability and why it matters BPC-157 has been reported as stable in gastric fluid ex vivo for extended periods, on the order of 24 hours in reported assays, while most peptides are degraded rapidly under gastric conditions by pepsin and acid hydrolysis